Xealth, InsightRX among 11 finalists of Accenture HealthTech Innovation Challenge

  • Small
  • Medium
  • Large

Eleven early-stage companies developing digital solutions to address social determinants of health, prescription drug pricing and more of healthcare's most pressing issues have advanced to the final stage of the Accenture HealthTech Innovation Challenge.

Accenture announced the finalists on Dec. 16, after they were chosen by a panel of executives representing some of the world's largest healthcare organizations. The 11 startups will compete in a final round of judging at the Accenture Innovation Hub in Houston in February 2020.

Here are the 11 finalists of the Accenture HealthTech Innovation Challenge, backed by Accenture's health segment and Accenture Ventures, the company's tech-focused investment arm.

  • Capital Rx (New York City)
  • Carrot Health (Minneapolis)
  • Cleo (San Francisco)
  • DynamiCare Health (Boston)
  • InsightRX (San Francisco)
  • Lantum (London)
  • Mira (Washington, D.C.)
  • Orderly Health (Denver)
  • Paloma Health (New York City)
  • TCARE (St. Louis)
  • Xealth (Seattle)

More articles on innovation:
UAB Health CINO Dr. Rubin Pillay on why innovation begins with rigorous training sessions: 'Innovation does not happen spontaneously'
NYU Langone opens biotech incubator with 22 industry members
Wake Forest Baptist Health, Verily developing interventions to improve senior independence

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars